LANCL2 drugs for Ulcerative Colitis

2 tracked LANCL2 drugs in the Ulcerative Colitis race. The class explanation lives on the LANCL2 page; the full indication pipeline across every mechanism is on the Ulcerative Colitis page.

1 Phase 21 preclinical / unstaged

Head-to-head evidence: NIM-1324 vs omilancor

The roster

← all LANCL2 drugs